Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation and application of recombinant protein cfp-10 nanoparticles

A technology of CFP-10 and recombinant protein, applied in medical preparations of non-active ingredients, antibacterial drugs, microcapsules, etc., can solve the problems of missing RD1 region and limited protective effect of adults, etc., to improve IgA level and promote BCG immune effect, effect of reducing tissue load

Active Publication Date: 2021-01-05
CHINA AGRI UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Bacillus Calmette-Guerin (BCG) is the most widely used vaccine to prevent tuberculosis. It has a significant protective effect on children, but has limited protective effect on adults. Compared with Mycobacterium bovis, BCG has certain gene defects, such as BCG missing the RD1 region, The protein encoded by its gene is closely related to the virulence of Mycobacterium tuberculosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application of recombinant protein cfp-10 nanoparticles
  • Preparation and application of recombinant protein cfp-10 nanoparticles
  • Preparation and application of recombinant protein cfp-10 nanoparticles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1: the preparation method of recombinant protein CFP-10 nano vaccine

[0027] Preparation of nanoparticles by double emulsion method: according to the CFP10 gene sequence of M. The plasmid was transformed into E.coli BL21(DE3) competent cells for induced expression, and the expressed protein was purified and freeze-dried. Dissolve the purified and lyophilized protein in PBS solution to form an internal aqueous phase, inject the internal aqueous phase into the organic phase, and ultrasonically form colostrum, inject the colostrum into 1% PVA solution, ultrasonically form double emulsion, and Pour milk into 0.5% PVA solution, stir for 3-4 hours, and volatile oil phase. The recombinant protein CFP-10 nanoparticles can be obtained by centrifugal washing and freeze-drying. The specific operation steps are as follows:

[0028] (1) configuration of polylactic acid-glycolic acid copolymer PLGA solution;

[0029] Dissolve polylactic acid-glycolic acid copolymer PL...

Embodiment 2

[0038] Example 2: Physical Characterization and Morphological Observation of Nanoparticles

[0039] The samples prepared with the ratio of internal water phase and oil phase at 1:9 were characterized, and the particle size and potential were measured using a Malvern Zetasizer nanometer particle size potentiometer. The prepared CFP10 nanoparticles have an average particle size of about 247nm and a potential of -28.8mV. After being measured by an ultraviolet spectrophotometer, the encapsulation efficiency of the nanoparticles is calculated to be 80.53%. The results of scanning electron microscopy showed that the size of CFP10 nanoparticles was relatively uniform, and it was spherical with a smooth surface ( figure 1 ).

Embodiment 3

[0040] Example 3: Evaluation of Recombinant CFP-10 Protein Nanoparticles Enhanced BCG Immune Effect

[0041] The experimental animals were randomly divided into 5 groups, 9 mice in each group, divided into PBS (no immunization but challenge), BCG control group (BCG+PBS), BCG+rCFP-10, BCG+PBS-NPs (BCG+blank nano microparticles), BCG+rCFP-10-NPs (BCG+recombinant protein nanoparticles). Use BCG for the first free (10 6 CFU / monkey), and 4 weeks later, the first booster immunization with nanoparticles (rCFP-10 protein dose was 50 μg / bird) was carried out by nasal drops, with an interval of 2 weeks, a total of 3 times. Four weeks after the third immunization, 3 mice were randomly selected from each group to detect relevant immune indicators. The rest were challenged with the NTSE-2 strain (1000 CFU / bird) by nasal drops, and samples were taken for follow-up detection after 4 weeks.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
electric potential / voltageaaaaaaaaaa
encapsulation rateaaaaaaaaaa
Login to View More

Abstract

The invention provides a preparation method of recombinant protein CFP-10 nanoparticles and the application thereof in preparing tuberculosis prevention vaccines. The preparation method includes the steps of (1) configuration of a polylactic acid-glycolic acid copolymer PLGA solution; (2) configuration of a recombinant protein CFP-10 solution; (3) preparation of primary emulsion; (4) preparation of compound emulsion; (5) formation of the nanoparticles. The recombinant protein CFP-10 nanoparticles prepared by the preparation method are used for enhancing the immunity of BCG-immunized mice through intranasal drip, and it is confirmed that the recombinant protein CFP 10 nanoparticles have the effects of improving mucosal immunity level and promoting BCG immunity.

Description

technical field [0001] The invention belongs to the field of new vaccine applications, and in particular relates to the preparation of recombinant protein CFP-10 nanoparticles and its application in the preparation of tuberculosis prevention vaccines. Background technique [0002] Bovine tuberculosis is an important zoonotic disease, which endangers the development of breeding industry and public health security. The causative bacterium of bovine tuberculosis is Mycobacterium bovis, which can break through the interspecies barrier and spread between other mammals and humans. It has a wide range of hosts and affects many mammal groups. The current investigation and research shows that bovine tuberculosis in my country has the characteristics of easy recurrence and national distribution, and it is transmitted to humans through food and contact. Bacillus Calmette-Guerin (BCG) is the most widely used vaccine to prevent tuberculosis. It has a significant protective effect on chi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/34A61K39/04A61P31/06
CPCA61K9/5153A61K39/04A61P31/06
Inventor 周向梅李淼煊梁正敏
Owner CHINA AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com